ADMD began formal negotiations for the creation of strategic relationships to produce and sell medical isotopes in Taiwan and China.
Initiated discussions for the construction of regional PET isotope production centers in Los Angeles, California and Oahu, Hawaii.
ADMD commenced three international advanced technology collaborative development projects for production and isotopic separation capability, offering high-value products not available from other sources.
Completed a strategic acquisition of a competitive firm, thereby establishing ADMD's position as a marketplace supplier through international sales of the O-18 isotope.
Sentiment: Strong Buy
Now that is some good information. Thank you. Better than the repetitive reposts of old news that is so common around here. Was this company plan made available for the greater public or was it presented only for larger investors or company employees. Where may I view this information first hand? Thank you.